TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Common Stock, Shares Authorized from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Teva Pharmaceutical Industries Ltd quarterly Common Stock, Shares Authorized history and growth rate from Q1 2010 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 2.5B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.5B 0 0% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 2.5B 0 0% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 2.5B 0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 2.5B 0 0% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 2.5B 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 2.5B +2.49B Jun 30, 2023 10-Q 2023-08-02
Q1 2023 2.5B 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 2.5B 0 0% Dec 31, 2022 10-K 2024-02-12
Q3 2022 2.5B 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 2.5K* -2.49B Jun 30, 2022 10-Q 2022-07-27
Q1 2022 2.5B 0 0% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 2.5B 0 0% Dec 31, 2021 10-K 2023-02-10
Q3 2021 2.5B 0 0% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 2.5B 0 0% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 2.5B 0 0% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 2.5B 0 0% Dec 31, 2020 10-K 2022-02-09
Q3 2020 2.5B 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 2.5B 0 0% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 2.5B 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 2.5B 0 0% Dec 31, 2019 10-K 2021-02-10
Q3 2019 2.5B 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 2.5B 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 2.5B 0 0% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 2.5B 0 0% Dec 31, 2018 10-K 2020-02-21
Q3 2018 2.5B Sep 30, 2018 10-Q 2018-11-01
Q2 2018 2.5B Jun 30, 2018 10-Q 2018-08-02
Q1 2018 2.5B Mar 31, 2018 10-Q 2018-05-03
Q4 2017 2.5B -5M -0.2% Dec 31, 2017 10-K 2019-02-19
Q4 2016 2.5B 0 0% Dec 31, 2016 20-F 2017-02-15
Q3 2016 2.5B 0 0% Sep 30, 2016 6-K 2016-11-15
Q2 2016 2.5B 0 0% Jun 30, 2016 6-K 2016-08-04
Q1 2016 2.5B 0 0% Mar 31, 2016 6-K 2016-05-09
Q4 2015 2.5B 0 0% Dec 31, 2015 20-F 2017-02-15
Q3 2015 2.5B 0 0% Sep 30, 2015 6-K 2015-10-29
Q2 2015 2.5B 0 0% Jun 30, 2015 6-K 2015-07-30
Q1 2015 2.5B 0 0% Mar 31, 2015 6-K 2015-04-30
Q4 2014 2.5B 0 0% Dec 31, 2014 20-F 2016-02-11
Q3 2014 2.5B 0 0% Sep 30, 2014 6-K 2014-10-30
Q2 2014 2.5B 0 0% Jun 30, 2014 6-K 2014-07-31
Q1 2014 2.5B 0 0% Mar 31, 2014 6-K 2014-05-02
Q4 2013 2.5B 0 0% Dec 31, 2013 6-K 2014-10-30
Q3 2013 2.5B 0 0% Sep 30, 2013 6-K 2013-10-31
Q2 2013 2.5B 0 0% Jun 30, 2013 6-K 2013-08-01
Q1 2013 2.5B 0 0% Mar 31, 2013 6-K 2013-05-02
Q4 2012 2.5B 0 0% Dec 31, 2012 6-K 2013-10-31
Q3 2012 2.5B 0 0% Sep 30, 2012 6-K 2012-11-01
Q2 2012 2.5B 0 0% Jun 30, 2012 6-K 2012-08-02
Q1 2012 2.5B 0 0% Mar 31, 2012 6-K 2012-05-09
Q4 2011 2.5B 0 0% Dec 31, 2011 6-K 2012-11-01
Q3 2011 2.5B 0 0% Sep 30, 2011 6-K 2011-11-02
Q2 2011 2.5B 0 0% Jun 30, 2011 6-K 2011-07-28
Q1 2011 2.5B +1B +66.7% Mar 31, 2011 6-K 2011-05-11
Q4 2010 2.5B Dec 31, 2010 6-K 2011-11-02
Q3 2010 2.5B Sep 30, 2010 6-K 2010-11-02
Q2 2010 2.5B Jun 30, 2010 6-K 2010-07-27
Q1 2010 1.5B Mar 31, 2010 6-K 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.